'Watershed moment’ as London medtech closes £1.75m funding round

Jun 4, 2018 · bdaily.co.uk


The medtech company behind a new blood filtration device has secured seven-figure funding.

London-based MediSieve Ltd secured the £1.75m boost from a mix of new and existing investors.

Private capital network 24Haymarket led the round by contributing £632k, with director Marek Gumienny joining the MediSieve board as non-executive director.

MediSieve said the investment will "contribute greatly" to further research and development while providing a strong source of future capital.

The company currently operates from office and lab space at Imperial College London’s Translation & Innovation Hub (I-HUB).

MediSieve is best known for its magnetic blood filtration technology, which targets blood-borne diseases by magnetically filtering specific disease-causing components in the bloodstream.

Read Complete Article

RT @LDN_talk: Are you using online government or public services, e.g. to pay your council tax, make a complaint or register to vote? Tell…

As Mayor, I look out for Londoners. And we need a public vote on Brexit. #peoplesvote #peoplesvotemarch https://t.co/SVYCdpjg9s

#TechX365: As more and more people work out of coffee shops on public WiFi, greater caution needs to be taken that… https://t.co/Z0HqKQ3o05

Prince Harry and Meghan unveil #Anzac memorial to Australia and New Zealand's war dead https://t.co/VCmn5hEx9A https://t.co/S2CSTuKacX

Bias-free AI: The importance of testing data sets https://t.co/C57vpeEpC4 by @TonyaHallRadio